China's Abogen Biosciences raises $92m in Series B round

Suzhou Abogen Biosciences has raised as much as 600-million yuan ($92 million) in its Series B round of funding to expand its operation, per an announcement.

The fresh round was jointly led by state-owned investment entities PICC Capital, and SDIC Venture Capital Management, besides YF Capital, a PE firm co-founded by Alibaba’s Jack Ma in 2010. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter